TRAILRUNNER-ALZ 3
TRAILRUNNER-ALZ 3 is a Phase 3 programme for remternetug. Recruiting status changes; check ClinicalTrials.gov.
Overview
An interventional amyloid-antibody study. Listing here is not a recommendation to enrol. Discuss eligibility only with a clinician and the study site.
Similar pages
not linked directly; found by shared links- TrialTRAILBLAZER-ALZ 2
Shares Eli Lilly, Alzheimer’s disease and the tag dementia-atlas.
- TrialEXPEDITION 3
Shares Eli Lilly, Alzheimer’s disease and the tag dementia-atlas.
- TargetAmyloid-beta
Shares Remternetug, Alzheimer’s disease and the tag dementia-atlas.
- PersonAlois Alzheimer
Shares Alzheimer’s disease and the tag dementia-atlas.
- TreatmentBrexpiprazole
Shares Alzheimer’s disease and the tag dementia-atlas.
- CollectionClinicalTrials.gov
Shares Alzheimer’s disease and the tag dementia-atlas.
- TreatmentMemantine
Shares Alzheimer’s disease and the tag dementia-atlas.
- InstitutionNational Institute on Aging
Shares Alzheimer’s disease and the tag dementia-atlas.